Blood Coagulants Market Scope And Analysis

  • Report Code : TIPRE00004416
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Blood Coagulants Market Report Scope 2021 to 2031

Buy Now

Blood Coagulants Market Report Blood Coagulants Market Size and Share Blood Coagulants Market Scope and Analysis

Blood Coagulants Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 7.3%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Drug class
  • Non-VKA Oral Anticoagulants
  • Heparin and Low-molecular-weight heparin
  • Vitamin K Antagonist
  • Others
By Route of administration
  • Oral
  • Injectable
By Bleeding Disorder Type
  • Hemophilia A
  • Hemophilia B
  • von Willebrand disease
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Aspen Holdings
  • Bayer AG
  • Bristol Myers Squibb Company
  • Baxter International Inc
  • Daiichi Sankyo Company
  • Grifols International SA Limited
  • GlaxoSmithKline Plc
  • Johnson Johnson Janssen Pharmaceuticals Inc
  • Novo Nordisk A S